An Australian Institute of Health and Welfare (AIHW) report based on pharmaceutical benefits scheme (PBS) data found that 25% of people prescribed oral bisphosphonates for osteoporosis stopped receiving their medication supply within six months and 10% of people only received one supply of medication. For oral bisphosphonates to be effective, they need to be taken consistently for 36 to 60 consecutive months. In high-risk patients, the duration of treatment with oral bisphosphonates needs to be even longer.
Are You Doing Your Best for Osteoporosis Patients? Optimising Osteoporosis Management and Facilitating Medication Adherence – Certificate of Completion
Australie
$0
gratuit
Certificate of Completion
2 hrs
Rheumatology, Musculoskeletal Health
4 Credits
Description du cours
Détails du cours
Date d'expiration : 2019-12-31
Métiers: Médecin
Faculté
Chrys Michaelides
MBBS,
Mater Hill Family Medical Centre
Woolloongabba, QLD
Professor Gustavo Duque
MD, PhD, FRACP
Professor and Chair of Medicine,
The University of Melbourne, VIC
Senior Staff Specialist
Western Health, St. Albans, VIC
Weiwen Chen
MBBS, FRACP, MSCOA
PhD Candidate Bone Biology Division
Garvan Institute of Medical Research,
Visiting Medical Officer St Vincent’s Hospital
Bone and Calcium Outpatient Clinic, Sydney NSW
Endocrinologist Sydney Medical Specialist, Sydney NSW
Accréditation
This interactive online learning activity is valued at 2 Hour(s) of continuing education.
Objectif(s) d'apprentissage
On completion of this program, participants will be better able to:
- Recall the incidence of knee osteoarthritis and describe the pathophysiology, signs and symptoms of knee osteoarthritis
- Describe the process for making a diagnosis of knee osteoarthritis
- Identify treatment options for knee osteoarthritis, including non-surgical options
- Evaluate when to refer suitable patients for non-surgical options such as viscosupplementation.